Ipsen (IPSEY) Stock Price, News & Analysis

Company Overview

Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, and rare diseases. Its product pipeline comprises Cabometyx + Atezolizumab, which is in phase III clinical trial for the treatment of second line metastatic castration-resistant prostate cancer; lenalidomide and rituximab, and Taverik, which is in phase III for the treatment of second line follicular lymphoma; Bylvay, which is in phase III for the treatment of biliary atresia; Dysport, which is in phase III clinical trial for the treatment of chronic and episodic migraine; Fidrisertib, which is in phase II clinical trial for the treatment of fibrodysplasia ossificans progressiva; Elafibranor, which is in phase II for the treatment of primary sclerosing cholangitis, as well as IPN60250; IPN10200, which is in phase II for the treatment of longer-acting neurotoxin aesthetics and therapeutics; IPN60210, which is in phase I clinical trial for the treatment of relapsed/refractory multiple myeloma; and IPN60260 for the treatment of Viral cholestatic disease and is in phase I clinical trial. The company also offers Somatuline, Decapeptyl, Cabometyx, Onivyde, Tazverik, and other oncology products; Dysport and other neurosciences products; and Bylvay, NutropinAq, Increlex, and Sohonos for rare diseases. The company was founded in 1929 and is based in Boulogne-Billancourt, France.

Key Stats

• Today's Range: $28.46 to $29.20
• 50-Day Range: $25.77 to $30.95
• 52-Week Range: $25.11 to $34.06
• Volume: 1,173 shs
• Average Volume: 5,538 shs
• Market Capitalization: $9.54 billion
• P/E Ratio: N/A
• Dividend Yield: 0.74%
• Price Target: N/A
• Consensus Rating: Buy

IPSEY Stock Analysis - Frequently Asked Questions

How have IPSEY shares performed this year?

Ipsen's stock was trading at $28.97 at the beginning of the year. Since then, IPSEY stock has decreased by 1.8% and is now trading at $28.46.
View the best growth stocks for 2025 here.

How do I buy shares of Ipsen?

Shares of IPSEY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 5/13/2025
• Next Earnings (Estimated): 7/31/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Diagnostic substances
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:IPSEY
• CIK: N/A
• Web: www.ipsen.com
• Phone: (315) 833-5000
• Fax: 33-01-58-33-50-01
• Employees: 5,325
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.14
• Quick Ratio: 0.98

Sales & Book Value

• Annual Sales: $3.87 billion
• Price / Sales: 2.47
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 335,258,000
• Free Float: N/A
• Market Cap: $9.54 billion
• Optionable: Not Optionable
• Beta: 0.54